The Technical Analyst
Select Language :
CNS Pharmaceuticals Inc [CNSP]

Exchange: NASDAQ Sector: Healthcare Industry: Biotechnology

CNS Pharmaceuticals Inc Price, Forecast, Insider, Ratings, Fundamentals & Signals

CNS Pharmaceuticals Inc is listed at the  Exchange

-1.84% $0.362

America/New_York / 28 mar 2024 @ 16:00


CNS Pharmaceuticals Inc: Main Fundamentals PE comparison

FUNDAMENTALS
MarketCap: 3.05 mill
EPS: -7.60
P/E: -0.0500
Earnings Date: Mar 31, 2024
SharesOutstanding: 8.43 mill
Avg Daily Volume: 0.410 mill
RATING 2024-03-28
B-
Neutral
RATINGS
Rating CashFlow: Strong Buy
Return On Equity: Strong Buy
Return On Asset: Strong Sell
DE: Strong Sell
P/E: Sell
Price To Book: Strong Sell
QUARTER GROWTHS
2/223/224/221/232/233/23
Revenuen/an/an/an/an/an/a
Gr.Profitn/an/a
Ebit
Asset
Debt
PE RATIO: COMPANY / SECTOR
0.00x
Company: PE -0.0500 | sector: PE -3.05
PE RATIO: COMPANY / INDUSTRY
-0.01x
Company: PE -0.0500 | industry: PE 5.88
DISCOUNTED CASH FLOW VALUE
N/A
N/A
Expected Trading Range (DAY)

$ 0.304 - 0.420

( +/- 16.02%)
ATR Model: 14 days

Insider Trading

Date Person Action Amount type
2024-02-01 Mahery Amy Buy 12 420 Option to purchase common stock
2024-02-01 Gumulka Jerzy Buy 33 333 Series B Warrant to purchase common stock
2024-02-01 Gumulka Jerzy Buy 33 333 Series A Warrant to purchase common stock
2024-02-01 Gumulka Jerzy Buy 33 333 Common stock
2024-02-01 Evans Carl Anthony Buy 33 333 Series B Warrant to purchase common stock
INSIDER POWER
93.51
Last 86 transactions
Buy: 3 691 286 | Sell: 2 431 436

Forecast: 16:00 - $0.384

Live Trading Signals (every 1 min)

Forecast 1: 16:00 - $0.384
Forecast 2: 16:00 - $0.384
Forecast 3: 16:00 - $0.384
SCORE
10.00
Buy
Score Algorithm Version: 1.2C
Last version updated: Fri April 15th, 2022
Indicator Signals
RSI 21
SMA
Trend
Trend 2
Trend 3
MACD
Volume Signals
Price $0.362 (-1.84% )
Volume 0.181 mill
Avg. Vol. 0.410 mill
% of Avg. Vol 44.09 %
Signal 1:
Signal 2:

Today

Intraday chart data with high, low, open and close for CNS Pharmaceuticals Inc

Last 12 Months

Last 12 months chart data with high, low, open and close for CNS Pharmaceuticals Inc

RSI

Intraday RSI14 chart for CNS Pharmaceuticals Inc

Last 10 Buy & Sell Signals For CNSP

0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%

Avg return buy: 0.00 % | Avg return sell: 0.00 %

$1 invested is now $1.00 or 0.00% since Coming Soon

Date Signal @ Closed %
Profile picture for
            CNS Pharmaceuticals Inc

CNSP

CNS Pharmaceuticals, Inc., a clinical pharmaceutical company, engages in the development of anti-cancer drug candidates for the treatment of brain and central nervous system tumors. The company's lead drug candidate is Berubicin, an anthracycline that is in Phase I and II clinical trials that is used for the treatment of glioblastoma multiforme. It has license agreements with Houston Pharmaceuticals, Inc. and The University of Texas M.D. Anderson Cancer Center, as well as Animal Life Sciences, LLC; and a development agreement with WPD Pharmaceuticals Inc., as well as a collaboration agreement with Reata Pharmaceuticals, Inc. The company was incorporated in 2017 and is based in Houston, Texas.

Last 10 Buy Signals

Date Signal @
BNBUSDMar 29 - 09:31$615.19
TIMEUSDMar 29 - 09:3232.37
AGLDUSDMar 29 - 09:301.650
MINAUSDMar 29 - 09:29$1.238
CBKUSDMar 29 - 09:281.087
METAMar 28 - 16:00$485.58
MSTRMar 28 - 16:00$1 704.56
STORJUSDMar 29 - 09:26$0.817
WNEARUSDMar 29 - 09:237.06
BIFIUSDMar 29 - 09:18438.25

Latest Press Releases

Latest News

Disclaimer:

"JimStromberg.com" is a research service that provides financial data and technical analysis of publicly traded stocks. All users should speak with their financial advisor before buying or selling any securities. Users should not base their investment decision upon "JimStromberg.com". By using the site you agree and are held liable for your own investment decisions and agree to Terms of Use and Privacy Policy. Please read the full disclaimer here.